Enhanced Delivery of Therapeutic siRNA into Glioblastoma Cells Using Dendrimer-Entrapped Gold Nanoparticles Conjugated with β-Cyclodextrin
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Enhanced Delivery of Therapeutic siRNA into Glioblastoma Cells Using Dendrimer-Entrapped Gold Nanoparticles Conjugated with β-Cyclodextrin
Authors
Keywords
-
Journal
Nanomaterials
Volume 8, Issue 3, Pages 131
Publisher
MDPI AG
Online
2018-02-28
DOI
10.3390/nano8030131
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Multifunctional PEI-entrapped gold nanoparticles enable efficient delivery of therapeutic siRNA into glioblastoma cells
- (2017) Lingdan Kong et al. Biomaterials Science
- Efficient delivery of therapeutic siRNA into glioblastoma cells using multifunctional dendrimer-entrapped gold nanoparticles
- (2016) Lingdan Kong et al. Nanomedicine
- Dendrimer-entrapped gold nanoparticles modified with β-cyclodextrin for enhanced gene delivery applications
- (2016) Jieru Qiu et al. RSC Advances
- Partially PEGylated dendrimer-entrapped gold nanoparticles: a promising nanoplatform for highly efficient DNA and siRNA delivery
- (2016) Wenxiu Hou et al. Journal of Materials Chemistry B
- Partially Acetylated Dendrimer-Entrapped Gold Nanoparticles with Reduced Cytotoxicity for Gene Delivery Applications
- (2015) Wenxiu Hou et al. JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
- Poly(amidoamine) Dendrimers Modified with 1,2-Epoxyhexane or 1,2-Epoxydodecane for Enhanced Gene Delivery Applications
- (2015) Tongyu Xiao et al. JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
- SiRNA-phospholipid conjugates for gene and drug delivery in cancer treatment
- (2014) Hongmei Liu et al. BIOMATERIALS
- Self-assembling gelling formulation based on a crystalline-phase liquid as a non-viral vector for siRNA delivery
- (2014) Lívia Neves Borgheti-Cardoso et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Antisense oligonucleotides against TNFR1 prevent toxicity of TNF/IFNγ treatment in mouse tumor models
- (2014) Filip Van Hauwermeiren et al. INTERNATIONAL JOURNAL OF CANCER
- Target Gene Knockdown by 2′,4′-BNA/LNA Antisense Oligonucleotides in Zebrafish
- (2014) Motoyuki Itoh et al. Nucleic Acid Therapeutics
- Dendrimer-entrapped gold nanoparticles modified with folic acid for targeted gene delivery applications
- (2013) Tongyu Xiao et al. Biomaterials Science
- Gene delivery using dendrimer-entrapped gold nanoparticles as nonviral vectors
- (2012) Yuebin Shan et al. BIOMATERIALS
- Biodegradable arginine-based poly(ether ester amide)s as a non-viral DNA delivery vector and their structure–function study
- (2012) Jun Wu et al. JOURNAL OF MATERIALS CHEMISTRY
- PEGylated Poly(amidoamine) dendrimer-based dual-targeting carrier for treating brain tumors
- (2010) Hai He et al. BIOMATERIALS
- PEG-conjugated PAMAM Dendrimers Mediate Efficient Intramuscular Gene Expression
- (2009) Rong Qi et al. AAPS Journal
- Gene delivery using functional dendritic polymers
- (2009) Constantinos M Paleos et al. Expert Opinion on Drug Delivery
- Transfection efficiencies of PAMAM dendrimers correlate inversely with their hydrophobicity
- (2009) Antos Shakhbazau et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Activated and non-activated PAMAM dendrimers for gene delivery in vitro and in vivo
- (2009) Gemma Navarro et al. Nanomedicine-Nanotechnology Biology and Medicine
- Biodegradable PAMAM ester for enhanced transfection efficiency with low cytotoxicity
- (2008) Hye Yeong Nam et al. BIOMATERIALS
- Nonviral Vectors for Gene Delivery
- (2008) Meredith A. Mintzer et al. CHEMICAL REVIEWS
- Brewster Angle Microscopy and PMIRRAS Study of DNA Interactions with BGTC, a Cationic Lipid Used for Gene Transfer
- (2008) Sabine Castano et al. LANGMUIR
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started